Though the causes of costochondritis are still unknown, hormonal imbalance is a vague possibility
It is therefore tempting to add GLP-1R agonists to the small list of glucose-lowering agents that exert anti-inflammatory actions independent of changes in glucoregulation
Other factors that may contribute to nausea during retatrutide treatment include: Central nervous system effects : GLP-1 receptors are present in brain regions involved in nausea and vomiting, including the area postrema, and activation of these pathways is thought to contribute to the emetogenic effects of this drug class [15] [16] Dose escalation : Rapid increases in dose are more likely to provoke symptoms than gradual titration Individual variability : Genetic, metabolic, and lifestyle factors can influence how sensitive a person is to these effects Dietary habits : Eating large, fatty, or rich meals may worsen nausea in those taking GLP-1-based therapies These mechanisms are not unique to retatrutide and are shared to varying degrees across the entire class of incretin-based medicines
In this paper, researchers noted that creatine levels in the body decline steadily over a three-month period in women following a vegetarian diet
Kerner J, Yohannes E, Lee K, Virmani A, Koverech A, Cavazza C, et al
Taking the right dose helps to optimize the benefits while minimizing risks, such as a headache or nausea
